Intelligent Bio Solutions (INBS) Stock Statistics & Valuation Metrics

Intelligent Bio Solutions has a market cap or net worth of $5.87M. The enterprise value is $109.56K.

Market Cap

$5.87M

Enterprise Value

$109.56K

Intelligent Bio Solutions has 3,316,803 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

3,316,803

Owned by Insiders

2.73%

Owned by Institutions

5.34%

Intelligent Bio Solutions’s return on equity (ROE) is -2.26 and return on invested capital (ROIC) is -176.09%.

Return on Equity (ROE)

-2.26

Return on Assets (ROA)

-1.04

Return on Invested Capital (ROIC)

-176.09%

Return on Capital Employed (ROCE)

-1.80

Revenue Per Employee

71.44K

Profits Per Employee

-210.69K

Employee Count

59

Asset Turnover

0.35

Inventory Turnover

5.17

The current PE Ratio of Intelligent Bio Solutions is -0.18. Intelligent Bio Solutions’s PEG ratio is -0.00.

PE Ratio

-0.18

PS Ratio

1.38

PB Ratio

0.92

Price to FCF

-0.48

Price to Operating Cash Flow

-0.42

PEG Ratio

-0.00

In the last 12 months, Intelligent Bio Solutions had revenue of 4.22M and earned -12.43M in profits. Earnings per share was -8.44.

Revenue

4.22M

Gross Profit

2.05M

Operating Income

-12.61M

Pretax Income

-12.47M

Net Income

-12.43M

EBITDA

-11.29M

Earnings Per Share (EPS)

-8.44

In the last 12 months, operating cash flow was -12.08M and capital expenditures -128,571, giving a free cash flow of -12.20M billion.

Operating Cash Flow

-12.08M

Free Cash Flow

-12.20M

Free Cash Flow per Share

-4.20

Intelligent Bio Solutions pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-201.07%

Earnings Yield

-233.79%

Beta

1.36

52-Week Price Change

-79.25%

50-Day Moving Average

1.86

200-Day Moving Average

2.93

Relative Strength Index (RSI)

53.45

Average Volume (3m)

143.18K

Intelligent Bio Solutions upcoming earnings date is Nov 05, 2026, TBA (Not Confirmed).

Last Earnings Date

Nov 05, 2026

Next Earnings Date

Nov 05, 2026

Ex-Dividend Date

―

Intelligent Bio Solutions as a current ratio of 1.44, with Debt / Equity ratio of 33.01%

Current Ratio

1.44

Quick Ratio

1.35

Debt to Market Cap

0.54

Net Debt to EBITDA

0.19

Interest Coverage Ratio

-1174.37

In the past 12 months, Intelligent Bio Solutions has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Intelligent Bio Solutions EV to EBITDA ratio is -0.34, with an EV/FCF ratio of -0.32.

EV to Sales

0.92

EV to EBITDA

-0.34

EV to Free Cash Flow

-0.32

EV to Operating Cash Flow

-0.32

Intelligent Bio Solutions has $3.99M in cash and marketable securities with $1.82M in debt, giving a net cash position of $2.17M billion.

Cash & Marketable Securities

$3.99M

Total Debt

$1.82M

Net Cash

$2.17M

Net Cash Per Share

$0.66

Tangible Book Value Per Share

$0.86

Gross margin is 27.71%, with operating margin of -305.03%, and net profit margin of -294.91%.

Gross Margin

27.71%

Operating Margin

-305.03%

Pretax Margin

-295.80%

Net Profit Margin

-294.91%

EBITDA Margin

-273.62%

EBIT Margin

-301.23%

The average price target for Intelligent Bio Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

38.09%

EPS Growth Forecast

54.22%

Smart Score

―

AI Score

44